INTRODUCTION TO SAMPLE-SIZE DETERMINATION AND POWER ANALYSIS FOR CLINICAL-TRIALS

被引：757

作者：

LACHIN, JM

机构：

来源：

CONTROLLED CLINICAL TRIALS | 1981年 / 2卷 / 02期

关键词：

D O I：

10.1016/0197-2456(81)90001-5

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：93 / 113

页数：21

共 20 条

[1] Cochran W.G., 1964, EXPT DESIGNS
[2] CUTLER SJ, 1958, J CHRON DIS, V8, P699
[3] CORRELATION COEFFICIENTS MEASURED ON SAME INDIVIDUALS
DUNN, OJ
CLARK, V
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1969, 64 (325) : 366 - &
[4] FLEISS JL, 1973, STATISTICAL METHODS
[5] IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS
FREIMAN, JA
CHALMERS, TC
SMITH, H
KUEBLER, RR
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) : 690 - 694
[6] PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT
GEORGE, SL
DESU, MM
[J]. JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2): : 15 - 24
[7] Gross AJ., 1975, SURVIVAL DISTRIBUTIO
[8] SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY
HALPERIN, M
ROGOT, E
GURIAN, J
EDERER, F
[J]. JOURNAL OF CHRONIC DISEASES, 1968, 21 (01): : 13 - &
[9] JOHNSON NL, 1970, DISTRIBUTIONS STATIS, V2
[10] LACHIN J, 1979, GUIDELINES DETECTION, P119